Literature DB >> 16763732

Ultrastructural study of myxoma virus morphogenesis.

J-L Duteyrat1, J Gelfi, S Bertagnoli.   

Abstract

Poxviruses are among the largest and most complex viruses known. Vaccinia virus, the prototype of the family Poxviridae, has been studied much more than myxoma virus. The aim of this work was to have a better knowledge about myxoma virus morphogenesis. The characterization of the main stages of MV morphogenesis was achieved by ultrastructural and immunological analysis. Specific antibodies were raised against M022L and M071L, two envelope proteins of extracellular enveloped virus and intracellular mature virus, respectively. The main stages of assembly were similar to those seen with other poxviruses, and the duration of the whole replication cycle was estimated to be around 16 h, longer than what was described for vaccinia virus. Morphological changes of infected cells were associated with the development of long cellular projections and enlarged microvilli. Intracellular enveloped viruses are associated with the cytoskeleton to move through the cell. Unlike earlier studies, as many cell-associated enveloped viruses as intracellular enveloped viruses were observed in relation with specialized microvilli, although these structures were rarely noticed. Finally, an unusual spreading process was observed, which uses cytoplasmic corridors.

Entities:  

Mesh:

Year:  2006        PMID: 16763732     DOI: 10.1007/s00705-006-0791-2

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  13 in total

1.  Infection of nonhost species dendritic cells in vitro with an attenuated myxoma virus induces gene expression that predicts its efficacy as a vaccine vector.

Authors:  S Top; E Foulon; B Pignolet; M Deplanche; C Caubet; C Tasca; S Bertagnoli; G Meyer; G Foucras
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  Loss of cytoskeletal transport during egress critically attenuates ectromelia virus infection in vivo.

Authors:  Helena Lynn; Jacquelyn Horsington; Lee Kuan Ter; Shuyi Han; Yee Lian Chew; Russell J Diefenbach; Michael Way; Geeta Chaudhri; Gunasegaran Karupiah; Timothy P Newsome
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Modulation of the myxoma virus plaque phenotype by vaccinia virus protein F11.

Authors:  Chad R Irwin; David H Evans
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

4.  Molecular characterisation of virulence graded field isolates of myxoma virus.

Authors:  Kevin P Dalton; Ines Nicieza; Aroa Baragaño; Jose Manuel Martín Alonso; Francisco Parra
Journal:  Virol J       Date:  2010-02-26       Impact factor: 4.099

5.  Inhibition of macrophage activation by the myxoma virus M141 protein (vCD200).

Authors:  Leiliang Zhang; Marianne Stanford; Jia Liu; Catherine Barrett; Lei Jiang; A Neil Barclay; Grant McFadden
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

6.  A whole-genome RNA interference screen for human cell factors affecting myxoma virus replication.

Authors:  Wondimagegnehu M Teferi; Kristopher Dodd; Rob Maranchuk; Nicole Favis; David H Evans
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

Review 7.  Arp2/3-mediated actin-based motility: a tail of pathogen abuse.

Authors:  Matthew D Welch; Michael Way
Journal:  Cell Host Microbe       Date:  2013-09-11       Impact factor: 21.023

8.  Myxoma virus oncolytic efficiency can be enhanced through chemical or genetic disruption of the actin cytoskeleton.

Authors:  Chad R Irwin; Nicole A Favis; Kate C Agopsowicz; Mary M Hitt; David H Evans
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

9.  Loss of Actin-Based Motility Impairs Ectromelia Virus Release In Vitro but Is Not Critical to Spread In Vivo.

Authors:  Melanie Laura Duncan; Jacquelyn Horsington; Preethi Eldi; Zahrah Al Rumaih; Gunasegaran Karupiah; Timothy P Newsome
Journal:  Viruses       Date:  2018-03-05       Impact factor: 5.048

10.  In vitro permissivity of bovine cells for wild-type and vaccinal myxoma virus strains.

Authors:  Béatrice Pignolet; Jean-Luc Duteyrat; Aude Allemandou; Jacqueline Gelfi; Gilles Foucras; Stéphane Bertagnoli
Journal:  Virol J       Date:  2007-09-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.